AEON Biopharma (AEON) Capital Expenditures (2022 - 2025)

AEON Biopharma (AEON) posted Capital Expenditures of $4000.0 for Q1 2025, down 55.56% sequentially from $9000.0 in Q4 2022.

AEON Biopharma (AEON) Capital Expenditures (2022 - 2025) Analysis & Trends

AEON Biopharma has reported Capital Expenditures for 2 years, with the latest figure at $4000.0 in Q1 2025.

Quarterly Capital Expenditures changed N/A year-over-year to $4000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $4000.0 (changed N/A YoY) and the FY2025 annual result came in at $4000.0, changed N/A from the prior year.
Capital Expenditures fell to $4000.0 in Q1 2025 per AEON's latest filing, from $9000.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $9000.0 in Q4 2022 and troughed at $4000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	37.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	25.02 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	34.68 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	6.26 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	251.02 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-73.57 Mn
10	AEON Biopharma	10.06 Mn	6.62 Mn	-	-

Download Data